SAHPRA and the Pfizer Booster (3rd dose) Vaccine

26 November 2021

Embargo: Immediate release

SAHPRA has received an application for the Pfizer Comirnaty Booster/3rddose vaccine on 17 November 2021.

This is for the homologous booster regimen, not a mix-and-match approach.

SAHPRA will now commence with the assessment of data for the safety and efficacy of the third dose.

The outcome of the assessment will be communicated in due course.

Download PDF